Oncopeptides saw the highest growth of 0.99% in patent filings and 1.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 1.99%. GlobalData’s DataBook provides a comprehensive analysis of Oncopeptides‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Oncopeptides has been focused on protecting inventions in Spain(ES) with one publication in Q2 2024
The Spain(ES) Patent Office dominates the patent grants with nearly 50% of grants. The South Korea(KR), World Intellectual Property Organization(WIPO), Spain(ES), and South Africa(ZA) patent Office are among the top ten patent offices where Oncopeptides is filings its patents. Among the top granted patent authorities, Oncopeptides has 50% of its grants in Spain(ES) and 50% in South Africa(ZA).
Roche could be the strongest competitor for Oncopeptides
Patents related to rare diseases lead Oncopeptides's portfolio
Oncopeptides has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Breast cancer related patents lead Oncopeptides portfolio followed by lung cancer, and ovarian cancer
Oncopeptides has highest number of patents in breast cancer followed by lung cancer, ovarian cancer, lymphoma, and bone sarcoma. For breast cancer, nearly 17% of patents were filed and 2% of patents were granted in Q2 2024.
For comprehensive analysis of Oncopeptides's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
